Correlation between Immune-Inflammatory Markers and Clinical Features in Patients with Acute Ischemic Stroke
CONCLUSIONS: Immune-inflammatory markers dynamically increased from symptom onset of acute ischemic stroke in patients eligible for thrombolytic therapy. Higher levels of immune-inflammatory markers suggest more in-hospital complications and unfavorable short-term outcomes.PMID:34018169
Source: Acta Neurologica Taiwanica - Category: Neurology Authors: Yu-Wei Chu Pei-Ya Chen Shinn-Kuang Lin Source Type: research
More News: Brain | Diabetes | Diabetes Mellitus | Emergency Medicine | Endocrinology | Ischemic Stroke | Neurology | Stroke | Taiwan Health | Thrombolytic Therapy | Thrombosis